Matches in DBpedia 2014 for { <http://dbpedia.org/resource/LGX818> ?p ?o. }
Showing items 1 to 36 of
36
with 100 items per page.
- LGX818 abstract "LGX818 is a drug candidate for the treatment of melanoma with the V600E mutation in the B-RAF kinase. The substance is being developed by Novartis, is in phase III clinical trials, and was disclosed at the spring 2013 American Chemical Society meeting in New Orleans.".
- LGX818 atcPrefix "None".
- LGX818 iupacName "Methyl [(2S)-1-{[4-(3-{5-chloro-2-fluoro-3-[(methylsulfonyl)amino]phenyl}-1-isopropyl-1H-pyrazol-4-yl)-2-pyrimidinyl]amino}-2-propanyl]carbamate".
- LGX818 thumbnail LGX818_structure.svg?width=300.
- LGX818 wikiPageID "39104975".
- LGX818 wikiPageRevisionID "595917462".
- LGX818 atcPrefix "None".
- LGX818 c "22".
- LGX818 chemspiderid "28536139".
- LGX818 cl "1".
- LGX818 f "1".
- LGX818 h "27".
- LGX818 inchi "1".
- LGX818 inchikey "CMJCXYNUCSMDBY-ZDUSSCGKBL".
- LGX818 iupacName "Methyl [-1-{[4--2-pyrimidinyl]amino}-2-propanyl]carbamate".
- LGX818 legalStatus "Investigational".
- LGX818 molecularWeight "540.011".
- LGX818 n "7".
- LGX818 o "4".
- LGX818 s "1".
- LGX818 smiles "C[C@@H]NCOC".
- LGX818 stdinchi "1".
- LGX818 stdinchikey "CMJCXYNUCSMDBY-ZDUSSCGKSA-N".
- LGX818 width "240".
- LGX818 subject Category:Cancer_treatments.
- LGX818 subject Category:Genetics.
- LGX818 type Drug.
- LGX818 type FunctionalSubstance.
- LGX818 comment "LGX818 is a drug candidate for the treatment of melanoma with the V600E mutation in the B-RAF kinase. The substance is being developed by Novartis, is in phase III clinical trials, and was disclosed at the spring 2013 American Chemical Society meeting in New Orleans.".
- LGX818 label "LGX818".
- LGX818 sameAs m.0t50y2h.
- LGX818 sameAs Q15409405.
- LGX818 sameAs Q15409405.
- LGX818 wasDerivedFrom LGX818?oldid=595917462.
- LGX818 depiction LGX818_structure.svg.
- LGX818 isPrimaryTopicOf LGX818.
